These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25079360)

  • 1. Genetic variant in folate homeostasis is associated with lower warfarin dose in African Americans.
    Daneshjou R; Gamazon ER; Burkley B; Cavallari LH; Johnson JA; Klein TE; Limdi N; Hillenmeyer S; Percha B; Karczewski KJ; Langaee T; Patel SR; Bustamante CD; Altman RB; Perera MA
    Blood; 2014 Oct; 124(14):2298-305. PubMed ID: 25079360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP2C9*8 is prevalent among African-Americans: implications for pharmacogenetic dosing.
    Scott SA; Jaremko M; Lubitz SA; Kornreich R; Halperin JL; Desnick RJ
    Pharmacogenomics; 2009 Aug; 10(8):1243-55. PubMed ID: 19663669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor warfarin dose prediction with pharmacogenetic algorithms that exclude genotypes important for African Americans.
    Drozda K; Wong S; Patel SR; Bress AP; Nutescu EA; Kittles RA; Cavallari LH
    Pharmacogenet Genomics; 2015 Feb; 25(2):73-81. PubMed ID: 25461246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study.
    Perera MA; Cavallari LH; Limdi NA; Gamazon ER; Konkashbaev A; Daneshjou R; Pluzhnikov A; Crawford DC; Wang J; Liu N; Tatonetti N; Bourgeois S; Takahashi H; Bradford Y; Burkley BM; Desnick RJ; Halperin JL; Khalifa SI; Langaee TY; Lubitz SA; Nutescu EA; Oetjens M; Shahin MH; Patel SR; Sagreiya H; Tector M; Weck KE; Rieder MJ; Scott SA; Wu AH; Burmester JK; Wadelius M; Deloukas P; Wagner MJ; Mushiroda T; Kubo M; Roden DM; Cox NJ; Altman RB; Klein TE; Nakamura Y; Johnson JA
    Lancet; 2013 Aug; 382(9894):790-6. PubMed ID: 23755828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of a proposed warfarin dosing algorithm based on the genetic make-up of Egyptian patients.
    Ekladious SM; Issac MS; El-Atty Sharaf SA; Abou-Youssef HS
    Mol Diagn Ther; 2013 Dec; 17(6):381-90. PubMed ID: 23839801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated analysis of genetic variation and gene expression reveals novel variant for increased warfarin dose requirement in African Americans.
    Hernandez W; Gamazon ER; Aquino-Michaels K; Smithberger E; O'Brien TJ; Harralson AF; Tuck M; Barbour A; Cavallari LH; Perera MA
    J Thromb Haemost; 2017 Apr; 15(4):735-743. PubMed ID: 28135054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing warfarin dose requirements in African-Americans.
    Momary KM; Shapiro NL; Viana MA; Nutescu EA; Helgason CM; Cavallari LH
    Pharmacogenomics; 2007 Nov; 8(11):1535-44. PubMed ID: 18034618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VKORC1 polymorphisms, haplotypes and haplotype groups on warfarin dose among African-Americans and European-Americans.
    Limdi NA; Beasley TM; Crowley MR; Goldstein JA; Rieder MJ; Flockhart DA; Arnett DK; Acton RT; Liu N
    Pharmacogenomics; 2008 Oct; 9(10):1445-58. PubMed ID: 18855533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New genetic variant that might improve warfarin dose prediction in African Americans.
    Schelleman H; Brensinger CM; Chen J; Finkelman BS; Rieder MJ; Kimmel SE
    Br J Clin Pharmacol; 2010 Sep; 70(3):393-9. PubMed ID: 20716240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting warfarin dosage in European-Americans and African-Americans using DNA samples linked to an electronic health record.
    Ramirez AH; Shi Y; Schildcrout JS; Delaney JT; Xu H; Oetjens MT; Zuvich RL; Basford MA; Bowton E; Jiang M; Speltz P; Zink R; Cowan J; Pulley JM; Ritchie MD; Masys DR; Roden DM; Crawford DC; Denny JC
    Pharmacogenomics; 2012 Mar; 13(4):407-18. PubMed ID: 22329724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of CYP2C9 and VKORC1 on warfarin response during initiation of therapy.
    Limdi NA; Wiener H; Goldstein JA; Acton RT; Beasley TM
    Blood Cells Mol Dis; 2009; 43(1):119-28. PubMed ID: 19297219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The missing association: sequencing-based discovery of novel SNPs in VKORC1 and CYP2C9 that affect warfarin dose in African Americans.
    Perera MA; Gamazon E; Cavallari LH; Patel SR; Poindexter S; Kittles RA; Nicolae D; Cox NJ
    Clin Pharmacol Ther; 2011 Mar; 89(3):408-15. PubMed ID: 21270790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing pharmacokinetics of warfarin in African-Americans: implications for pharmacogenetic dosing algorithms.
    Nagai R; Ohara M; Cavallari LH; Drozda K; Patel SR; Nutescu EA; Perera MA; Hernandez W; Kaneko N; Hibiya M; Takahashi H
    Pharmacogenomics; 2015; 16(3):217-25. PubMed ID: 25712185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of common and rare genetic variation on warfarin dose among African-Americans and European-Americans using the exome array.
    Liu N; Irvin MR; Zhi D; Patki A; Beasley TM; Nickerson DA; Hill CE; Chen J; Kimmel SE; Limdi NA
    Pharmacogenomics; 2017 Jul; 18(11):1059-1073. PubMed ID: 28686080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetic versus clinical dosing of warfarin in individuals of Chinese and African-American ancestry: assessment using data simulation.
    Syn NL; Lee SC; Brunham LR; Goh BC
    Pharmacogenet Genomics; 2015 Oct; 25(10):491-500. PubMed ID: 26230382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Race influences warfarin dose changes associated with genetic factors.
    Limdi NA; Brown TM; Yan Q; Thigpen JL; Shendre A; Liu N; Hill CE; Arnett DK; Beasley TM
    Blood; 2015 Jul; 126(4):539-45. PubMed ID: 26024874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and clinical predictors of warfarin dose requirements in African Americans.
    Cavallari LH; Langaee TY; Momary KM; Shapiro NL; Nutescu EA; Coty WA; Viana MA; Patel SR; Johnson JA
    Clin Pharmacol Ther; 2010 Apr; 87(4):459-64. PubMed ID: 20072124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetic-guided Warfarin Dosing Algorithm in African-Americans.
    Alzubiedi S; Saleh MI
    J Cardiovasc Pharmacol; 2016 Jan; 67(1):86-92. PubMed ID: 26355760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose requirements in African Americans.
    Voora D; Koboldt DC; King CR; Lenzini PA; Eby CS; Porche-Sorbet R; Deych E; Crankshaw M; Milligan PE; McLeod HL; Patel SR; Cavallari LH; Ridker PM; Grice GR; Miller RD; Gage BF
    Clin Pharmacol Ther; 2010 Apr; 87(4):445-51. PubMed ID: 20200517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics of warfarin dosing in patients of African and European ancestry.
    Shendre A; Dillon C; Limdi NA
    Pharmacogenomics; 2018 Nov; 19(17):1357-1371. PubMed ID: 30345882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.